| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Aclaris Therapeutics, Inc. (ACRS) has 6 insiders with recent SEC Form 4 filings, including 4 buys and 9 sells. ACRS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 13.95M | $62.77M | - | |
| Other | 510.0K | $2.29M | - | |
| COO | 336.3K | $1.51M | - | |
| CEO | 274.8K | $1.24M | - | |
| Other | 18.7K | $84.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 23, 2023 | Monahan Joseph87 | Chief Scientific Officer | Sell | 6,000 | $5.08 | $30,460.20 | -4.4% | -74.7% | -74.5% | |
| Sep 6, 2023 | Balthaser Kevin48 | Chief Financial Officer | Buy | 9,490 | $7.90 | $74,971.00 | +158.9% | -86.9% | -84.4% | |
| Aug 28, 2023 | Loerop James | Chief Business Officer | Buy | 14,705 | $6.80 | $99,958.71 | +210.6% | -86.8% | -82.0% | |
| Aug 21, 2023 | Monahan Joseph87 | Chief Scientific Officer | Sell | 6,000 | $7.32 | $43,894.80 | -4.2% | -87.2% | -83.0% | |
| Jun 20, 2023 | Monahan Joseph87 | Chief Scientific Officer | Sell | 6,000 | $10.28 | $61,662.60 | -4.1% | -30.0% | -89.4% | |
| Mar 17, 2023 | Manion Douglas J. | Pres And CEO | Buy | 6,300 | $7.86 | $49,532.49 | +96.9% | +25.6% | -85.2% | |
| Mar 9, 2023 | Manion Douglas J. | Pres And CEO | Buy | 6,500 | $7.74 | $50,277.50 | New | +22.5% | -81.6% | |
| Mar 3, 2023 | Walker Neal85 | Director | Sale+OE | 59,240 | $12.50 | $740,658.20 | -2.3% | -31.9% | -90.3% | |
| Mar 3, 2023 | Balthaser Kevin48 | Chief Financial Officer | Sale+OE | 1,894 | $12.45 | $23,578.52 | -16.1% | -31.9% | -90.3% | |
| Mar 3, 2023 | Monahan Joseph87 | Chief Scientific Officer | Sale+OE | 30,837 | $12.51 | $385,638.87 | -9.3% | -31.9% | -90.3% |